Senior Medical Education Grants Analyst at Genentech
San Francisco Bay Area
Senior Medical Education Grants Analyst at Genentech
San Francisco Bay Area
• Passionate about using my analytical expertise to create actionable information from data
• Experienced leader of interdisciplinary teams with a proven record of meeting, or exceeding goals for technical and analytical projects, while staying within budgets and deadlines
• Ability to consider the bigger picture and potential relevant scenarios and to develop robust strategic plans and prioritize accordingly, plus build alliances across organizations
• Broad understanding of key challenges facing the healthcare and pharmaceutical industries, including financial and economic principles and reimbursement mechanisms
• Experienced user of statistical software and programming in SAS, SPSS, S+, Stata, PASS, SUDAAN, CART, JMP, and Tableau.
Statistical Methodology, Healthcare Economics and Finance, Consulting, Sales Force Effectiveness, Statistics, Pharmaceutical and Biotechnology
(Privately Held; Biotechnology industry)
November 2007 — Present (2 years 3 months)
• Leading the design and implementation of the next generation grant management system
• Effectively led three IMED IT Projects totaling $1.6M through product life cycle process resulting in a decreased grant review time by 5 days (15%), despite a 20% increase in volume
• Designed and developed key metrics in support of IMED value proposition utilized in communications with internal and external stakeholders
• Created 27 standard BI reports depicting relevant metrics and ad hoc reporting capabilities by designing a usable data structure from unstructured data
• Served as primary liaison between IMED, Corporate Information Technology (CIT), and external vendor driving effective collaboration across all stakeholders
• Conducted an assessment of the medical education grant workflow and provided recommendations to enhance IMED efficiency
• Collaborated with IMED and external agency on the development and execution of a pilot to measure the educational impact of Genentech supported medical education
• Advised a cross-functional team on efforts to replace current trend tool for forecasting
• Acting as Co-chair of community outreach for Genentech Out and Equal
• Recognized with the Commercial Operations ACE Award of Excellence for the development of the IMED reporting capability and with the Business Practices Star Award for outstanding collaboration and teamwork
(Public Company; RX; Pharmaceuticals industry)
January 2007 — November 2007 (11 months)
•Enhanced current methodologies for physician segmentations, used to optimize sales force effectiveness, to incorporate anonymized patient level, managed care, and co-pay sensitivity data, as well as the statistical methods of CHAID regression trees and latent GOLD regression
(Public Company; RX; Pharmaceuticals industry)
July 2004 — January 2007 (2 years 7 months)
• Created methodology to obtain national average drug prices at the National Drug Code level on a consulting project for the Centers for Medicare and Medicaid Services
• Developed statistical methodology and provide support for development of the new methodology Next Generation Prescription Services (NGPS) which replaced legacy methodology for Xponent and NPA syndicated products, including assessment of PBM data utilization
• Analyzed Monte Carlo simulations in order to evaluate variability and accuracy of NGPS in comparison to legacy products and competitors’ methodology for marketing claims
• Conducted impact analysis and report of supply chain distribution patterns for retail pharmaceutical market used in successful contract negotiations with data suppliers
• Utilized jackknife methodology and general variance functions to create confidence intervals for NGPS estimates
• Provided project management and wrote technical specifications for NGPS specific tasks to meet deadlines
www.imshealth.com
(Educational Institution; 10,001 or more employees; Hospital & Health Care industry)
October 2001 — July 2004 (2 years 10 months)
· Authored or acknowledged for statistical analysis on over ten peer reviewed publications, as well as presented medical research findings at three professional society conferences
· Collaborated with investigators, faculty, and research teams to design studies, write grants and manuscripts, and prepare analysis for medical research hypotheses
· Conducted statistical analysis over a broad range of studies for presentations or manuscripts, as well as interim reports for presentation to Project Steering Committees and Safety Monitoring Boards
· Supervised analysts, programmers, and graduate students as appropriate
· Served as primary statistical consult to the Pulmonary, Allergy, and Critical Care Division
(Public Company; 10,001 or more employees; Food Production industry)
January 1999 — June 2001 (2 years 6 months)
· Provided statistical and programming services for the Global Nutrition and Health department
· Completed nutritional analysis of NHANES III and CSFII dietary databases to uncover dietary trends, eating habits, and fortification justification for target market segments
MBA/MS , Healthcare Management/Healthcare Financial Management , 2003 — 2006
MS , Statistics , 1998 — 2001
Worked on research study at UMDNJ for pre-natal risk factors associated with small birth weights across socio-economic groups of women from Camden, NJ one of the poorest cities in America. Attained first publication: Theresa O. Scholl, Xinhua Chen, Christina Gaughan, and Woollcott K. Smith Influence of Maternal Glucose Level on Ethnic Differences in Birth Weight and Pregnancy Outcome Am. J. Epidemiol. 2002 156: 498-506.
BA , Mathematics , 1994 — 1998
ASA, GPPN, Member of the Board of Directors of Sapphire Fund